Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
46 hedge funds and large institutions have $127M invested in Apollo Endosurgery, Inc. in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 7 closing their positions.
699% more call options, than puts
Call options by funds: $823K | Put options by funds: $103K
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
70% more capital invested
Capital invested by funds: $74.3M → $127M (+$52.2M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
10% more funds holding
Funds holding: 42 → 46 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$5.19M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$4.23M |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$2.03M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.68M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.71M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$1.61M |
| 3 |
SCM
SG Capital Management
Chicago,
Illinois
|
-$823K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$316K |
| 5 |
Millennium Management
New York
|
-$172K |
APEN Hedge Fund Activity: Q2 2021 in Review
46 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2021, worth a combined $127M — up 70% from $74.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new APEN positions and 7 closed out — a net gain of 4 holders — while 17 added to existing stakes and 6 trimmed.
The largest buyer was Archon Capital Management, opening a new position worth an estimated $5.19M. The largest seller was Stonepine Capital Management, cutting an estimated $4.71M.
- 46 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2021, up from 42 in Q1 2021.
- Funds reported $127M of Apollo Endosurgery, Inc. stock for Q2 2021, up 70% quarter-over-quarter.
- 11 funds opened new Apollo Endosurgery, Inc. positions in Q2 2021 and 7 closed out, a net change of +4 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q2 2021 was Archon Capital Management, an estimated $5.19M added.
- The largest Apollo Endosurgery, Inc. seller in Q2 2021 was Stonepine Capital Management, an estimated $4.71M sold.
Based on aggregated 13F filings for Q2 2021.